<scp>ER</scp> +, <scp>HER2</scp> − advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes

Authors :: Jessica W. Chen
William Jacot
Javier Cortés
Ian E. Krop
Susan Dent
Nadia Harbeck
Michelino De Laurentiis
Véronique Diéras
Young‐Hyuck Im
Thomas J. Stout
Frauke Schimmoller
Heidi M. Savage
Katherine E. Hutchinson
Timothy R. Wilson
Source :: Molecular Oncology.
Publication Year :: 2023
Publisher :: Wiley, 2023.

Subjects :: Cancer Research
Oncology
Genetics
Molecular Medicine
General Medicine

Full Text Access

Tools